(NASDAQ: ARAY) Accuray's forecast annual revenue growth rate of 4.83% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.77%.
Accuray's revenue in 2025 is $450,902,000.On average, 5 Wall Street analysts forecast ARAY's revenue for 2026 to be $54,930,779,624, with the lowest ARAY revenue forecast at $52,505,279,399, and the highest ARAY revenue forecast at $56,838,310,875. On average, 4 Wall Street analysts forecast ARAY's revenue for 2027 to be $57,156,799,456, with the lowest ARAY revenue forecast at $54,382,208,545, and the highest ARAY revenue forecast at $59,408,887,749.
In 2028, ARAY is forecast to generate $58,740,175,070 in revenue, with the lowest revenue forecast at $56,437,083,268 and the highest revenue forecast at $60,468,627,333.